Beyond her clinical practice, she serves as a researcher, frequently contributing to high-impact systematic reviews and meta-analyses. Research Highlights
Her clinical approach to based on her UK training.
the difference between the PRN and fixed regimens she studied. Search for any new studies she has released in 2026.
Thank you for being here. Whether you’ve followed me for years or just stumbled upon this page by accident—welcome. You belong here.
For those looking to explore ’s work, here are the essential titles: yan martha putri
This study, "Pro re nata versus fixed aflibercept regimen for neovascular age-related macular degeneration: a systematic review and meta-analysis," used rigorous methods to analyze the outcomes of existing clinical trials. The analysis showed that a fixed, bimonthly injection schedule of aflibercept was superior to an "as needed" (pro re nata) approach, leading to better visual acuity improvements after 12 months, with the standardized mean difference of 0.56 (95% CI 0.36–0.75, I² = 0%, p < 0.00001). The choice of aflibercept is significant as it was a relatively new anti-VEGF therapy at the time, and establishing optimal dosing schedules has important implications for patient outcomes.
The story of Yan Martha Putri is a testament to the fact that even when life takes an unexpected turn, success is still possible. She chose to get back up and build a new path for herself when the world around her was turned upside down. Her journey is a brilliant reminder of the power of courage, hard work, and the will to persevere.
AI Mode history New thread AI Mode history You're signed out To access history and more, sign in to your account Delete all searches? You won't be able to return to these responses Delete all Manage public links See my AI Mode history Shared public links
: Merging her research interests with clinical duties, she operated as a Research Assistant at RSCM Kirana, Indonesia's premier national ophthalmology center, advancing domestic eye-care standards. Beyond her clinical practice, she serves as a
To provide a solid blog post about , it is important to first identify her current professional focus, as she is an emerging figure in Indonesian architecture and interior design.
is a prominent Indonesian medical professional, researcher, and general practitioner celebrated for her contributions to geriatric care, age-related diseases, and clinical research. Graduating with high honors ( Cum Laude ) from the University of Indonesia and earning a Master of Research from Newcastle University, UK, she bridges the gap between frontline patient consultations and academic medical research. Her work significantly addresses global and regional healthcare challenges, particularly the impending clinical demands of an aging society and the intricacies of ophthalmic conditions like Age-Related Macular Degeneration (AMD). Academic Background and International Training
Analyzing clinical data to optimize treatment protocols for patients, aiming to balance visual improvement with treatment efficiency. Impact on Ophthalmology
: Previously, she worked as a General Practitioner at RS Murni Teguh Sudirman Jakarta (2022–2023) and RS Badan Pengusahaan Batam (2021). Search for any new studies she has released in 2026
: To expand her investigative skills, she pursued a Master of Research (MRes) in Aging and Health from Newcastle University , graduating with Merit honors. During her time in the United Kingdom, she contributed to the international student community through the Indonesian Student Association in the UK (PPI UK). Key Research Contributions
Yan Martha Putri has been involved in significant clinical research, particularly regarding infectious diseases and health outcomes in Indonesia. Key Research: HIV/AIDS Mortality in Indonesia
: Conducted a cross-sectional study on the knowledge, attitude, and practice regarding cervical cancer and HPV vaccination among medical students in Jakarta.
